×
Long-duration contracts are the anchor. A new five-year Defense Logistics Agency (DLA) suppressants framework and a renewed five-year CAL FIRE agreement are expected to convert into revenue starting late 2026, ramping through 2027 and reaching steady state beyond 2028, reducing the company's dependence on any single fire season. Acquisitions are diversifying the earnings base. The roughly $685 million purchase of Medical Manufacturing Technologies (MMT), a maker of medical-device manufacturing machinery, adds a recurring aftermarket stream to the Specialty Products segment and expands the portfolio beyond fire-safety demand.
The central target of $42 is the arithmetic mean of four verified analyst price targets, rounded from $41.50, and sits well above the latest close of $27.55 . Reaching $42 would require a gain of about 52% , a very large move by any conventional measure.
Perimeter Solutions (PRM) shares have been broadly flat over the last 30 days, easing roughly 0.9% from about $27.80 to $27.55. Over the trailing quarter, the stock has pulled back from the low-$30s — a decline of roughly 11% — as post-earnings momentum cooled after an August peak near $38.
45Z tax-credit runway is expanding: Management raised its 2026 expectation to at least $20 million in net Section 45Z clean fuel tax-credit earnings, with Columbia now qualifying for a higher per-gallon credit rate. Capacity and low-carbon initiatives are scaling: A Pekin dry-mill debottlenecking adds roughly 8% of annual capacity, while a first-of-its-kind low-carbon corn agreement positions the company for greater credit capture into 2027.
The $8.30 central target is the arithmetic mean of three verified analyst price targets, rounded from $8.33. The individual targets range from $7.00 to $10.00, with ratings of Buy across the board.
Alto Ingredients (ALTO) declined roughly 17% over the trailing 30 days, falling from a close near $3.59 to about $2.98 per share. The pullback accelerated in mid-November, with the stock sliding from $3.84 on November 11 to $2.98 by November 20 on elevated trading volume.
FSI pre-announced third-quarter 2026 revenue of roughly $14.35 million , up about 36% year over year from $10.56 million in Q3 2025. Consensus EPS (earnings per share) forecasts still call for a loss, ranging from about -$0.01 to -$0.04 , versus -$0.04 reported a year ago.
Flexible Solutions International reported third-quarter 2026 revenue of $14.35 million, up roughly 36% from $10.56 million in the same period a year earlier. Growth was driven by full operations at its Panama factory, a strong quarter in its ENP division, and continued progress in food-grade production.
FSI is Flexible Solutions International, Inc., a specialty chemicals and environmental technology company headquartered in Taber, Alberta, Canada. The company develops and manufactures products that conserve water and energy, operating through its energy and water conservation and biodegradable polymers businesses.
FutureFuel Corp (NYSE: FF) shares fell roughly 47% over the past 30 days, sliding from about $5.56 in late October to near $2.94. The decline was concentrated around the company's third-quarter 2026 earnings report, with shares sinking despite a 361% year-over-year jump in revenue.
FEAM declined roughly 46% over the past 30 days, sliding from about $2.70 to near $1.45, unwinding a sharp late-September and early-October rally. The pullback reflects a "sell the news" reversal following the Searles Valley Minerals acquisition, alongside a fiscal Q1 2027 earnings report that missed consensus estimates.
ASPI shares fell roughly 51% over the last 30 days, sliding from a closing price of $2.17 on October 21, 2026, to about $1.06 in recent trading. The decline extended a broader slide, with the stock down approximately 73% over the last three months from around $3.95 in late August 2026.
Standard Nuclear (STDN) fell from the prior close of $9.01 to $8.54, a -5.22% move, in regular-session trading Friday morning. No verified news or fundamental catalyst found; the drop is likely continued post-earnings de-rating, consistent with a -27.8% slide over the six sessions since the Nov. 12 report.
The central GEVO stock price target of $5 is the arithmetic mean of four verified analyst price targets, rounded from roughly $5.24. With the latest verified price near $1.70, reaching $5 would require a roughly 194% advance, a very large move relative to the stock's recent trading range.
Gevo (GEVO) shares climbed roughly 50% over the past 30 days, rising from about $1.13 to $1.70 per share. The rally was driven primarily by record third-quarter 2026 results reported in early November, including revenue of $83 million, up 94% year over year, and a swing to net income of $22.7 million.
Different industries, different risk profiles: BL (BlackLine) is a cloud financial-automation software provider, while CBT (Cabot Corporation) is a specialty chemicals and materials producer. Momentum diverges: BlackLine has posted strong margin expansion but faces elongated sales cycles and softer guidance, whereas Cabot is managing pricing pressure in its core tire-related segment.
Lightweight and crystal cat litter momentum: The integration of the Ultra Pet acquisition and rapid growth in co-packaged and lightweight litter lines position the consumer segment for continued expansion. Agricultural carriers as a growth engine: Record sales in agricultural and horticultural products, led by the Verge brand, offer a diversified source of demand beyond the core litter business.
The central target used in this analysis is $80 , reflecting roughly a 12% advance from the most recent verified close near $71.36 . This $80 figure is not an analyst consensus. It is a fallback objective tied to the widely watched 50-day and 200-day moving averages near $80–$81, a technical recovery zone frequently cited after the stock's sharp pullback from its $107 52-week high.
ODC shares traded near $71 in mid-November 2026, down roughly 1.4% over the trailing 30 days after a sharp pullback from the low-$90s in early October. Oil-Dri closed fiscal 2026 with record annual sales of $493.8 million and record net income of $57.0 million, capped by all-time-high fourth-quarter revenue of $129.3 million.
The central target used here is $13 , the arithmetic mean of three verified analyst price targets — Canaccord Genuity ($11), Cantor Fitzgerald ($13), and Lucid Capital ($15) — giving a low-to-high range of $11 to $15. With shares near $1.23, the stock would need to rise roughly 950% to reach $13, a very large move for a development-stage company.